|
PLEKHA1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.36820000002014E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.47620000060067E-08 |
| Normal-vs-Stage2 |
9.061200E-03 |
| Normal-vs-Stage3 |
8.720800E-03 |
| Normal-vs-Stage4 |
6.041400E-01 |
| Stage1-vs-Stage2 |
4.107000E-01 |
| Stage1-vs-Stage3 |
1.654200E-01 |
| Stage1-vs-Stage4 |
5.80580000000275E-05 |
| Stage2-vs-Stage3 |
7.506200E-01 |
| Stage2-vs-Stage4 |
2.722100E-02 |
| Stage3-vs-Stage4 |
4.404100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.35090000000326E-06 |
| Normal-vs-AfricanAmerican |
1.075400E-01 |
| Normal-vs-Asian |
5.069800E-02 |
| Caucasian-vs-AfricanAmerican |
3.810400E-02 |
| Caucasian-vs-Asian |
9.344600E-01 |
| AfricanAmerican-vs-Asian |
3.330200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.800700E-03 |
| Normal-vs-Female |
8.56600002041574E-09 |
| Male-vs-Female |
1.580280E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.818200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.00229999997226E-06 |
| Normal-vs-Age(61-80Yrs) |
1.417770E-04 |
| Normal-vs-Age(81-100Yrs) |
1.527830E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.607840E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.825850E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.563000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.668200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.282800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.311000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.163100E-03 |
| Normal-vs-Grade 2 |
1.71109999502761E-08 |
| Normal-vs-Grade 3 |
2.607500E-04 |
| Normal-vs-Grade 4 |
2.989400E-01 |
| Grade 1-vs-Grade 2 |
4.001200E-01 |
| Grade 1-vs-Grade 3 |
2.538500E-02 |
| Grade 1-vs-Grade 4 |
1.8296099999926E-05 |
| Grade 2-vs-Grade 3 |
8.399400E-03 |
| Grade 2-vs-Grade 4 |
5.90219983997997E-10 |
| Grade 3-vs-Grade 4 |
3.52970000000452E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.5527136788005E-15 |
| Normal-vs-ccB subtype |
6.428000E-01 |
| ccA subtype-vs-ccB subtype |
2.12052597703405E-14 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.80440000000048E-06 |
| Normal-vs-N1 |
3.648200E-01 |
| N0-vs-N1 |
9.787900E-04 |
|
|
